Cargando…

Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles

[Figure: see text]

Detalles Bibliográficos
Autores principales: Khoza, Leon J., Kumar, Pradeep, Dube, Admire, Demana, Patrick H., Choonara, Yahya E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169426/
https://www.ncbi.nlm.nih.gov/pubmed/35680110
http://dx.doi.org/10.1016/j.ijpharm.2022.121893
_version_ 1784721205572403200
author Khoza, Leon J.
Kumar, Pradeep
Dube, Admire
Demana, Patrick H.
Choonara, Yahya E.
author_facet Khoza, Leon J.
Kumar, Pradeep
Dube, Admire
Demana, Patrick H.
Choonara, Yahya E.
author_sort Khoza, Leon J.
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-9169426
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-91694262022-06-07 Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles Khoza, Leon J. Kumar, Pradeep Dube, Admire Demana, Patrick H. Choonara, Yahya E. Int J Pharm Article [Figure: see text] Elsevier B.V. 2022-06-25 2022-06-06 /pmc/articles/PMC9169426/ /pubmed/35680110 http://dx.doi.org/10.1016/j.ijpharm.2022.121893 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Khoza, Leon J.
Kumar, Pradeep
Dube, Admire
Demana, Patrick H.
Choonara, Yahya E.
Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles
title Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles
title_full Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles
title_fullStr Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles
title_full_unstemmed Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles
title_short Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles
title_sort insights into innovative therapeutics for drug-resistant tuberculosis: host-directed therapy and autophagy inducing modified nanoparticles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169426/
https://www.ncbi.nlm.nih.gov/pubmed/35680110
http://dx.doi.org/10.1016/j.ijpharm.2022.121893
work_keys_str_mv AT khozaleonj insightsintoinnovativetherapeuticsfordrugresistanttuberculosishostdirectedtherapyandautophagyinducingmodifiednanoparticles
AT kumarpradeep insightsintoinnovativetherapeuticsfordrugresistanttuberculosishostdirectedtherapyandautophagyinducingmodifiednanoparticles
AT dubeadmire insightsintoinnovativetherapeuticsfordrugresistanttuberculosishostdirectedtherapyandautophagyinducingmodifiednanoparticles
AT demanapatrickh insightsintoinnovativetherapeuticsfordrugresistanttuberculosishostdirectedtherapyandautophagyinducingmodifiednanoparticles
AT choonarayahyae insightsintoinnovativetherapeuticsfordrugresistanttuberculosishostdirectedtherapyandautophagyinducingmodifiednanoparticles